Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
27985
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Study part: Prior + concomitant diseases. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 1/1/18 1/1/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 7, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Diseases GOAL Trial B-cell Lymphoma NCT02499003
Diseases GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Diseases GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
relevant medical conditions
Item
Are there any relevant medical conditions?
boolean
Disease number
Item
No.
integer
Disease specification
Item
Disease, specify term:
text
Start date
Item
Start date
date
Stop date
Item
Stop date
date
Ongoing disease at End of Treatment
Item
Ongoing at End of Treatment?
boolean
No comments